Nervous System Malignancies Flashcards

1
Q

3 characteristics of neoplasms

A

*autonomous - growth is independent of physiologic growth signals
*clonal - acquired mutations affect cell and its progeny
*proliferative - mutations confer cell survival and growth advantage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

benign vs. malignant neoplasms

A

*differentiation - how well do neoplastic cells resemble normal?
*invasion - is there infiltration/destruction of surrounding tissues?
*metastasis - has neoplasm spread to physically discontinuous sites?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

behavior of neuro neoplasms

A

*benign vs. malignant distinction less evident in the brain:
-confined space in skull
-widely infiltrate the brain parenchyma
-may be lethal if situated in critical brain region, even if “benign”

*patterns of spread differs from other organ systems
-may spread within CNS through the CSF
-rarely metastasize to other organ systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

primary neuro neoplasms

A

*from cells intrinsic to the nervous system
*locally infiltrative and destructive
*approx 66% of neuro neoplasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

metastatic neuro neoplasms

A

*from other organ systems (LUNG, breast, kidney, skin)
*multiple, well-circumscribed lesions at gray-white matter junction
*approx 33% of neuro neoplasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

typical adult neuro neoplasms

A

*SUPRAtentorial/cerebral hemispheres
*types: glioblastoma, meningioma, schwannoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

typical childhood neuro neoplasms

A

*INFRAtentorial/posterior fossa
*account for nearly 20% of all cancers in childhood
*types: pilocytic astrocytoma, ependymoma, medulloblastoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

risk factors of neuro neoplasms

A

*most CNS tumors are sporadic
*about 1% are hereditary
*immunosuppression - strongly associated with primary CNS lymphoma
*RADIATION is a strong risk factor, esp for gliomas and meningiomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

neurofibromatosis type 1

A

*inherited neoplastic syndrome
*gene = NF1 (17q11)
*tumor types = neurofibroma, pilocytic astrocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

neurofibromatosis type 2

A

*inherited neoplastic syndrome
*gene = NF2 (22q12)
*tumor types = schwannoma, meningioma, ependymoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

tuberous sclerosis

A

*inherited neoplastic syndrome
*gene = TSC1/TSC2 (9q34/16p13)
*tumor types = subependymal giant cell astrocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Von Hippel-Lindau

A

*inherited neoplastic syndrome
*gene = VHL (3p25)
*tumor type = hemangioblastoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Li-Fraumeni

A

*inherited neoplastic syndrome
*gene = TP53 (17p13)
*tumor types = gliomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

primary neuro neoplasms - classification

A

*glial tumors/gliomas (astrocytomas, oligodendrogliomas, ependymomas)
*embryonal tumors (medulloblastomas)
*meningiomas
*nerve sheath tumors (schwannomas)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what types of things cause ring-enhancing lesions on MRI of brain

A

*high-grade gliomas (ex. glioblastomas)
*abscesses
*central nervous system toxoplasmosis
*organizing infarcts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

gliomas - overview

A

*neoplasms of glial cell origin (non-specific)
*types: astrocytomas, oligodendrogliomas, ependymomas
*tissue biopsy required to confirm dx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

gliomas - general characteristics

A

-no recognizable premalignant or in situ stages
-produce major clinical abnormalities
-rarely spread outside CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

gliomas - signs and symptoms

A

*focal OR generalized signs/symptoms:
-headaches, seizures, aphasia, vomiting, visual disturbances
-cognitive dysfunction (memory + mood disorders)
-intracranial pressure may be increased
-suspected on basis of imaging studies (MRI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

grade I glioma

A

*slow growing and unlikely to spread
*survival > 5 years; curable if excised
*general category = benign (pilocytic astrocytoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

grade II glioma

A

*unlikely to grow and spread, but more likely to come back after treatment
*survival > 5 years; tendency to recur
*general category = low grade malignant (oligodendroglioma, diffuse astrocytoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

grade III glioma

A

*grow quickly with rapidly dividing cells, but no necrosis
*survival 2-3 years
*general category = high grade malignant (anaplastic astrocytoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

grade IV glioma

A

*grow and spread quickly with rapidly dividing cells; has vascular proliferation and necrosis
*survival < 1 year
*general category = high grade malignant (glioblastoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

astrocytoma - pathogenesis

A

*mutation of IDH1 (or IDH2)
*mutated genes encode forms of isocitrate dehydrogenase with new enzymatic activity
*presence of IDH1/2 mutations predicts better prognosis in all grades of astrocytic tumors

24
Q

astrocytomas - overview

A

*neoplasms of astrocytes
*specific type of glioma

25
classifications of astrocytomas
*non-infiltrative/localized: pilocytic astrocytoma (grade I) *infiltrative: -diffuse astrocytoma (grade II) -anaplastic astrocytoma (grade III) -glioblastoma (grade IV)
26
pilocytic astrocytoma - overview
*BENIGN neoplasm of astrocytes (grade I); non-infiltrative -most common benign CNS tumor in children -very slow growing, usually arises in cerebellum
27
pilocytic astrocytoma - pathogenesis
*mutations/translocations involving BRAF (functions in RAS signaling pathway) *IDH1 mutations NOT seen
28
pilocytic astrocytoma - appearance
*discrete CYSTIC lesion with mural nodules *biphasic architecture: loose "microcystic" and compact, densely fibrillar areas *ROSENTHAL FIBERS: bright-red corkscrew-shaped astrocyte inclusion
29
infiltrative astrocytomas - overview
*MALIGNANT neoplasms of astrocytes (grade II-IV) *account for 80% of adult gliomas, usually in the 40s-60s *low-grade tumors progress to high-grade tumors *on imaging, low grade is non-enhancing, and high-grade is enhancing
30
diffuse astrocytoma
*grade II (infiltrative) astrocytoma *most common in young adults *IDH1 mutations *transition between neoplastic and normal tissues not distinct: -infiltrate diffusely -increased cellular astrocyte proliferation with atypia -mitoses RARE -microvascular proliferation + necrosis ABSENT
31
anaplastic astrocytoma
*grade III (infiltrative) astrocytoma *IDH1 mutations *transition between neoplastic and normal tissues not distinct: -mitoses increased -microvascular proliferation -necrosis ABSENT
32
glioblastoma
*grade IV (infiltrative) astrocytoma *most common and most malignant primary brain tumor or adults (commonly crosses corpus callosum - "butterfly" lesion) *NOT associated with IDH1, unless progression from lower grade *transition between neoplastic and normal tissues not distinct: -highly pleomorphic -mitoses numerous -extensive endothelial proliferation and areas of necrosis
33
oligodendrogliomas
*malignant neoplasm of oligodendrocytes *constitute 5-15% of gliomas *best prognosis among glial tumors (survival of 10-20 years, depending on grading)
34
oligodendrogliomas - gene defect
*IDH1/2 mutation AND *deletion of 1p and 19q
35
oligodendrogliomas - clinical features
patients may have had several years of neurologic complaints, often including seizures
36
oligodendrogliomas - gross features
*usually frontal lobe *predilection for white matter *gelatinous, gray masses, often cystic, focal hemorrhages, and calcifications
37
oligodendrogliomas - histological features
*regular cells with spherical nuclei *clear halo cytoplasm, "fried eggs" *grade II = low mitotic activity *grade III = anaplastic, higher cell density, anaplasia, increased mitoses, necrosis
38
ependymomas - overview
*malignant neoplasm of ependymal cells *10% of pediatric brain tumors (typically posterior fossa) *in adults, typically spinal cord (22q deletion ; NF2 gene mutation)
39
ependymomas - clinical features
*posterior fossa -> non communicating hydrocephalus (progressive obstruction of 4th ventricle) *CSF dissemination uncommon
40
ependymomas - pathology
*cells with fibrillary processes contain regular nuclei *canals = glandlike elongated structures with lumen (resembling embryologic ependymal canal) *pseudorosettes = perivascular nuclear-free zones
41
embryonal tumor (medulloblastoma) - overview
*malignant neoplasm of cerebellar stem cells *accounts for almost 20% of pediatric tumors *most tumors located cerebellum midline *molecular groups vary in terms of age of onset, tumor location, and prognosis
42
embryonal tumor (medulloblastoma) - clinical features
*posterior fossa -> non communicating hydrocephalus (progressive obstruction of 4th ventricle) *CSF dissemination: meningeal "icing" or spinal "drop mets" *highly malignant; however, exquisitely radiosensitive
43
embryonal tumor (medulloblastoma) - pathology
*densely cellular, undifferentiated small blue cells (embryonal) *Homer-Wright rosettes surrounding central neuropil
44
meningioma - overview
*predominantly benign neoplasms of arachnoid meningothelial cells *found along any of the external surfaces of the brain (usually attached to dura) *most common benign CNS tumor in adults (rare in children)
45
meningioma - pathogenesis
*loss of long arm chromosome 22 (22q deletion) -including NF2 gene, which encodes the protein merlin -about 50% of sporadic meningiomas have loss-of-function mutations of NF2 *increased risk with prior radiation therapy to head/neck
46
meningioma - clinical features
*slow-growing, solitary tumors *vague non-localizing, or focal referable symptoms to adjacent brain compression *may express variety of hormones (grow rapidly during pregnancy)
47
meningioma - gross features
*round mass attached to dura (may compress underlying brain) *common sites: -parasagittal convexity -lateral convexity -sphenoid wing, olfactory groove, sella turcica
48
meningioma - histologic features
*push, rather than infiltrate *compact clusters/whorls of cells *psammomatous calcifications *malignant variants = high grade)
49
CNS metastatic disease
*metastatic meningeal or parenchymal brain lesions *account for 25-50% of intracranial tumors
50
CNS metastatic disease - clinical features
*may be first manifestation of systemic disease *present as mass lesions: may be multiple; meningeal carcinomatosis *common primary sites = LUNG, breast, skin, kidney, GI
51
CNS metastatic disease - pathology
*intraparenchymal sharply demarcated masses (usually at gray-white matter junction) *typically resemble parent tumor type (phenotyping helpful for identifying the primary neoplastic site)
52
schwannoma - overview
*benign neoplasm of Schwann cells *nerve sheath tumors *arise directly from peripheral or cranial nerves (may arise within dura) *inactivating mutations of NF2 gene on chromosome 22
53
schwannoma - clinical features
*local compression of involved nerve or adjacent structures *dural: acoustic neuroma (attached VIII: vestibular branch; present with tinnitus and hearing loss) *extradural *surgical removal is curative
54
schwannoma - gross features
*well-circumscribed, firm gray encapsulated masses *attached loosely to associated nerve without invading *lesion displaces nerve of origin as it grows *can often be resected without sacrificing nerve function
55
schwannoma - histologic features
*Schwann cells with spindled/wavy, elongated nuclei *a mixture of dense and loose zones: -Antoni A = dense cellular areas -Antoni B = loose cellular areas